Koers Vical Incorporated Nasdaq
Aandelen
US9256021042
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 6,94 mln. 6,52 mln. | Omzet 2023 | 8,01 mln. 7,51 mln. | Marktkapitalisatie | 5,25 mln. 4,93 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -21 mln. -19,71 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,69 mln. | EV/omzet 2022 | -0,59 x |
Nettoliquiditeiten 2022 | 8,63 mln. 8,1 mln. | Nettoliquiditeiten 2023 | 10,87 mln. 10,2 mln. | EV/omzet 2023 | -0,7 x |
K/w-verhouding 2022 |
-0,2
x | K/w-verhouding 2023 |
-0,83
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 01-12-20 |
Nancy Seretta
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-16 |
Aaron Fox-Collis
AUD | Comptroller/Controller/Auditor | - | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-15,84% | 21,4 mld. | |
-9,21% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-14,65% | 16,09 mld. | |
+4,39% | 13,83 mld. | |
+31,35% | 11,97 mld. |
- Beurs
- Aandelen
- Koers FRTX
- Koers